/

/

Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today - Avicanna (OTC:AVCNF)

Mon, Apr 14

Why did @AvicannaInc $AVCNF $AVCN surge 26% today? 🤯 📈 $25.5M revenue (+52%) 💸 Gross margin up to 51% 💊 Clinical advances: EB, pain, epilepsy 📦 200K units sold 🇨🇴 Trunerox approved in Colombia 🔬 2 new U.S. patents Full story via @Benzinga: 🔗 https://t.co/Cw5pqe18QH

2232

Shares of Avicanna Inc.

Discover